Accolade, Inc. (ACCD)

Market Cap	326.43M
Revenue (ttm)	431.53M
Net Income (ttm)	-88.99M
Shares Out	80.01M
EPS (ttm)	-1.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,479,810
Open	3.970
Previous Close	3.850
Day's Range	3.920 - 4.110
52-Week Range	3.350 - 15.360
Beta	2.00
Analysts	Buy
Price Target	10.88 (+166.67%)
Earnings Date	Jun 27, 2024

About ACCD

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management speci...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jul 2, 2020
• Employees: 2,400
• Stock Exchange: NASDAQ
• Ticker Symbol: ACCD

Financial Performance

In 2023, Accolade's revenue was $414.29 million, an increase of 14.09% compared to the previous year's $363.14 million. Losses were -$99.81 million, -78.29% less than in 2022.

Analyst Forecast

According to 12 analysts, the average rating for ACCD stock is "Buy." The 12-month stock price forecast is $10.88, which is an increase of 166.67% from the latest price.

Price Target

$10.88

(166.67% upside)

Analyst Consensus: Buy